Securities Code: 300255 Securities Abbreviation: Changshan Pharmaceutical Announcement Number: 2026-22 Hebei Changshan Biochemical Pharmaceutical Co., Ltd. 2025 Annual General Meeting Resolution Announcement
The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
I. Meeting Convening and Attendance
Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") issued a notice to all shareholders on April 29, 2026, to convene the 2025 Annual General Meeting. This meeting was held using a combination of on-site voting and online voting. The on-site meeting was held at 14:30 on May 19, 2026, in the conference room of the office building of Hebei Changshan Biochemical Pharmaceutical Co., Ltd., located at No. 71, Menglong Street, South District, High-tech Industrial Development Zone, Zhengding County, Zhengding County, Hebei (China) Pilot Free Trade Zone. The meeting was convened by the Board of Directors and presided over by Chairman Mr. Gao Xiaodong. The online voting period through the Shenzhen Stock Exchange trading system was from 9:15-9:25, 9:30-11:30, and 13:00-15:00 on May 19, 2026. The online voting period through the Shenzhen Stock Exchange internet voting system was from 9:15 to 15:00 on May 19, 2026.
A total of 426 shareholders attended the meeting, representing 297,063,467 voting shares, or 32.3225% of the Company's total voting shares. Among them, 6 shareholders attended the on-site meeting, representing 282,353,128 voting shares, or 30.7219% of the Company's total voting shares. 420 shareholders participated in online voting, representing 14,710,339 voting shares, or 1.6006% of the Company's total voting shares. A total of 424 minority shareholders (excluding company directors, senior management, and shareholders holding 5% or more of the shares individually or in aggregate) attended the meeting, representing 14,888,739 voting shares, or 1.6200% of the Company's total voting shares.
Some of the Company's directors and lawyers attended or were present at the meeting.
The convening, holding, and voting procedures of the meeting complied with the relevant provisions of the "Company Law," "Articles of Association," and "Shareholder Meeting Rules."
II. Voting on Proposals
The meeting voted on each proposal using a combination of on-site and online voting, and the following proposals were approved:
- Approval of the Proposal on the Board of Directors' Work Report for 2025